Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes

NCT02597101 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Insulin Resistance

Interventions

DRUG: Metformin
DRUG: saxagliptin
DRUG: AZD9668
DRUG: placebo

Sponsor

Nick Giannoukakis, PhD

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]